Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.50 |
| ▸ | HTR1A | P08908 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6293775 | 1.00 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6290609 | 1.00 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6289586 | 0.97 | L3MBTL1 (0.56) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6290676 | 0.97 | ALDH1A1 (0.61) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6293841 | 0.95 | L3MBTL1 (0.58) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6289268 | 0.89 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6290343 | 0.85 | PARP10 (0.61) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6293904 | 0.85 | PARP10 (0.61) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL2458461 | 0.85 | PARP10 (0.61) | ALDH1A1L3MBTL1MAPK1HTTLMNA | |
| SCHEMBL6293879 | 0.85 | PARP10 (0.61) | ALDH1A1L3MBTL1MAPK1HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1225456-C | Novel aromatic diamine and its polyimide | MITSUI CHEMICALS INC (JP) | 2005-11-02 | — | — | CN | disclosed |
| US-6933411-B2 | Aromatic diamine and polyimide thereof | MITSUI CHEMICALS, INC. (JP) | 2005-08-23 | — | — | US | disclosed |
| US-6737503-B2 | LOW TEMPERATURE ADHESIVE BONDING | MITSUI CHEMICALS, INC. (JP) | 2004-05-18 | — | — | US | disclosed |
| US-20040082754-A1 | Novel aromatic diamine and polyimide thereof | MITSUI CHEMICALS, INC. (JP) | 2004-04-29 | — | — | US | disclosed |
| US-20030092870-A1 | Novel aromatic diamine and polyimide thereof | MITSUI CHEMICALS, INC. (JP) | 2003-05-15 | — | — | US | disclosed |
| CN-1403438-A | Novel aromatic diamine and its polyimide | MITSUI CHEMICALS INC (JP) | 2003-03-19 | — | — | CN | disclosed |
| EP-1288191-A2 | Novel aromatic diamine and polyimide thereof | Mitsui Chemicals, Inc. (JP) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092870-A1 | Novel aromatic diamine and polyimide thereof | DDT, AOC1, H1-4 | ALDH1A1 902/4885L3MBTL1 2546/4885MAPK1 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.